---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-132111"
form_type: "8-K"
ticker: "AUTL"
cik: "0001730463"
company_name: "Autolus Therapeutics plc"
filed_at: "2025-05-30T23:59:59+00:00"
generated_at: "2026-05-20T04:33:55.155354+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Autolus directors Anderson and Murphy will not stand for re-election at 2025 AGM

## Summary
- Joseph Anderson and Martin Murphy notified the board on May 23, 2025, of their decision.
- Both directors stated the decision was not due to any disagreement with management or the board.
- Their departure takes effect at the 2025 Annual General Meeting of Shareholders.

## SEC filing metadata
- accession: 0001193125-25-132111
- form_type: 8-K
- ticker: AUTL
- cik: 0001730463
- company_name: Autolus Therapeutics plc
- filed_at: 2025-05-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1730463/000119312525132111/0001193125-25-132111-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1730463/000119312525132111/d908343d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-132111
- JSON: https://secwatch.observer/filing/0001193125-25-132111.json
- Plain text: https://secwatch.observer/filing/0001193125-25-132111.txt

## Key facts
- Executive change
  Martin Murphy departed as Director at Autolus Therapeutics plc.
  - Action: not stand for re-election
  - Role: Director
  source text: On May 23, 2025, Drs. Joseph Anderson and Martin Murphy, members of the Board of Directors (the “Board”) of Autolus Therapeutics plc (the “Company”), notified the Company of their intention not to stand for re-election at the Company’s 2025 Annual General Meeting of Shareholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1730463/000119312525132111/0001193125-25-132111-index.htm
- Executive change
  Joseph Anderson departed as Director at Autolus Therapeutics plc.
  - Action: not stand for re-election
  - Role: Director
  source text: On May 23, 2025, Drs. Joseph Anderson and Martin Murphy, members of the Board of Directors (the “Board”) of Autolus Therapeutics plc (the “Company”), notified the Company of their intention not to stand for re-election at the Company’s 2025 Annual General Meeting of Shareholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1730463/000119312525132111/0001193125-25-132111-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.